홈 › 비소세포폐암 › 오하이오

오하이오의 비소세포폐암 임상 시험

비소세포폐암 관련 연구 123개가 오하이오 내 여러 지역에서 참여자를 모집하고 있습니다.

오하이오의 도시

공식 연구 텍스트(영어)

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Dayton Physician's Network, Dayton

피험자 모집 중3상

18세 ~ 100세 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT05920356

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

Cleveland Clinic Taussig Cancer Institute Case Comprehensive Cancer Center, Cleveland

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07111520

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

University Hospitals Cleveland Medical Center, Cleveland
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C, Columbus

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07100080

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

University Hospitals Seidman Cancer Center at UH Avon Health Center, Avon
University Hospitals Cleveland Medical Center, Cleveland
University Hospitals Seidman Cancer Center at UH Mentor Health Center, Mentor
외 1개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06758401

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Aultman Health Foundation, Canton
Miami Valley Hospital South, Centerville
Ohio State University Comprehensive Cancer Center, Columbus
외 5개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06498635

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Cleveland Clinic Akron General, Akron
Strecker Cancer Center-Belpre, Belpre
Aultman Health Foundation, Canton
외 34개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT04267848

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

University of Cincinnati Medical Center-University of Cincinnati Cancer Center ( Site 0103), Cincinnati

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06345729

Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

Cleveland Clinic, Cleveland

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT04886804

A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer

Cleveland Clinic, Cleveland

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06868485

Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)

Local Institution - 0438, Sandusky

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07680790

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

University of Cincinnati Medical Center ( Site 0119), Cincinnati

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT06623422

A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)

The James Cancer Hospital and Solove Research Institute, Columbus

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT07541170

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Local Institution - 0486, Centerville
University of Cincinnati Medical Center, Cincinnati
Local Institution - 0512, Zanesville

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT06561386

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

University Hospitals Seidman Cancer Center at UH Avon Health Center, Avon
Oncology_Hematology Care Clinical Trials,LLC, Cincinnati
Oncology_Hematology Care Clinical Trials,LLC, Cincinnati
외 5개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07144280

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

ProMedica Flower Hospital, Sylvania

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07388524

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Ohio State University, Columbus

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06793215

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Akron General Medical Center, Akron
The Christ Hospital, Cincinnati
University Hospitals Cleveland Medical Center, Cleveland
외 2개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07361497

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

University Hospitals Cleveland Medical Center, Cleveland

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06465069

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Aultman Hospital, Canton
Miami Valley Hospital South, Centerville
Fairview Hospital, Cleveland
외 4개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06890598

Adaptive Chemotherapy for Pd-l1 High REsEctablE NSCLC: A Chemo-PHREE Trial

University Hospitals Seidman Cancer Center, Cleveland
Ohio State University Comprehensive Cancer Center, Columbus

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07746388

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Ohio State University Comprehensive Cancer Center (OSUCCC)- The James Cancer Hospital and Solove Research Institute, Columbus

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05579366

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Indu and Raj Soin Medical Center, Beavercreek
Strecker Cancer Center-Belpre, Belpre
Saint Elizabeth Boardman Hospital, Boardman
외 11개

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06418204

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

The Ohio State University (OSU) Wexner Medical Center, Columbus

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06400472

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Miami Valley Hospital South, Centerville
USO - Oncology Hematology Care, Cincinnati
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06119581